Partnering for Speed.

The RDI is partnering with pharmaceutical companies, rare disease testing labs, providers and patient advocacy groups to ensure that a patient is quickly identified for testing, diagnosis, treatment and/or as a clinical trial candidate for a rare disease. Each party has a role to play and RDI’s aim is to optimize the sequence that will best serve the patient.

RDI drives earlier diagnosis via smarter and more efficient pharmaceutical research and testing programs

Our common goal is to improve patient outcomes.

With an earlier and more accurate diagnosis and improved access to care we can move the needle on helping patients shorten the diagnostic journey. Understanding which physicians are seeing patients identified as good prospects for testing and treatment is an integral part of the RDI’s role.

Our Partners